InvestorsHub Logo

DesertEagle

01/16/19 5:46 PM

#47420 RE: SAMNOTSAMUEL #47419

SNS, fully agree with your observations. Problem is Delcath is not forthcoming with enrollment information so for investors it is a roll of the dice when to invest.

Also agree since major investors tired of the game and moved on survival has been the primary objective of the company.

As noted before, dilution has already begun. With millions of shares waiting in the wings most likely will be able to judge the speed at which it is occurring when the annual report is released in March.

As always, appreciate your insights.

Bond

01/16/19 5:57 PM

#47422 RE: SAMNOTSAMUEL #47419

If you paid attention to the dilution table list they came up with before ER, the only party who was diluting before year end was HB/Alto listed as November 2017/ February 2018 holders, they are the one who had those last 1 million plus warrants, they are gone so is the dilution for now.
all other 0.01$ warrants are held with DGF and they are not seems to be executing anything from long time.
I predict shares shortage scenario if DGF never sells anything till we go way higher than 1.75$.
thoughts?

In my mind company is finally completely out of HB mess and their stock damaging tactics.

Game is back in to DGF's hands now.

DGF= Discover growth fund